The Global Bioactive Peptide Market is driven by Rising Demand for...

The Global Bioactive Peptide Market is driven by Rising Demand for Nutraceuticals

Posted 2024-06-19 11:25:52

685

The bioactive peptide market is witnessing lucrative demand from consumers seeking functional foods and nutraceuticals. As a constituent of nutraceuticals, bioactive peptides provide various health benefits including boosting immunity, lowering blood pressure, controlling blood sugar levels, and enhancing digestive health. The growing awareness about the medicinal properties of bioactive peptides is prompting nutritional supplement manufacturers to incorporate peptides into their products. A large number of bioactive peptide supplements marketed for general wellness, cognitive performance, stress relief, and weight management are gaining worldwide popularity. Continuous new product launches and promotional activities by leading food firms are further driving the uptake of bioactive peptides in everyday diet.

The Global Bioactive Peptide Market is estimated to be valued at US$ 11.29 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.

The growing demand for Bioactive Peptide Market Demand from nutraceuticals and functional food industries is a major factor propelling the market growth. Some of the key health benefits of bioactive peptides including regulation of blood pressure, blood cholesterol, and blood sugar levels are increasing their adoption in dietary supplements targeting metabolic disorders and cardiovascular health.

North America and Europe collectively account for a sizeable revenue share in the global bioactive peptide market due to rising health-consciousness among consumers and increasing usage of bioactive peptide-based supplements as alternatives to pharmaceutical products in these regions. However, the Asia Pacific bioactive peptide market is expected to expand at the fastest rate over the forecast period supported by growing markets for nutraceuticals and functional foods in China, Japan, and India.

Market Drivers

Rising prevalence of lifestyle diseases such as high blood pressure, obesity, and diabetes across global populations is a prime factor contributing to the increasing demand for functional foods and nutraceuticals containing bioactive peptides. Several clinical studies have demonstrated the antidiabetic, antihypertensive, and weight management properties of specific bioactive peptides, which is attracting more consumers towards bioactive peptide supplements. Rapid expansion of supplement, sports nutrition, and weight loss product categories where bioactive peptides can be utilized as active ingredients is expected to propel the bioactive peptide market growth over the coming years.